Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
1,668.93
775.05
570.56
965.41
738.14
958.39
762.47
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,668.93
775.05
570.56
965.41
738.14
958.39
762.47
Raw Material Cost
242.54
226.55
235.29
292.82
350.27
290.78
212.87
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
14.63
15.25
16.21
14.97
14.00
13.77
14.40
Selling and Distribution Expenses
234.93
248.45
221.38
194.42
125.25
118.10
274.66
Other Expenses
34.84
43.94
38.10
37.01
43.48
40.88
45.93
Total Expenditure (Excl Depreciation)
840.47
929.60
853.87
872.30
924.30
831.40
961.19
Operating Profit (PBDIT) excl Other Income
828.5
-154.60000000000002
-283.29999999999995
93.10000000000001
-186.20000000000002
127
-198.70000000000002
Other Income
55.30
34.72
-31.81
-69.13
96.72
-122.68
38.90
Operating Profit (PBDIT)
1,013.83
1.03
-195.72
141.83
31.92
125.23
-113.40
Interest
14.63
15.25
16.21
14.97
14.00
13.77
14.40
Exceptional Items
-4.52
-0.17
10.69
20.21
-27.02
55.93
-25.36
Gross Profit (PBDT)
1,426.39
548.50
335.28
672.59
387.87
667.61
549.59
Depreciation
130.06
120.86
119.39
117.85
121.36
120.92
46.42
Profit Before Tax
864.61
-135.25
-320.64
29.22
-130.46
46.47
-199.58
Tax
22.51
78.99
28.89
34.44
24.67
62.50
46.18
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
842.10
-214.24
-349.53
-5.21
-155.14
-16.03
-245.75
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
842.10
-214.24
-349.53
-5.21
-155.14
-16.03
-245.75
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
842.10
-214.24
-349.53
-5.21
-155.14
-16.03
-245.75
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
6,896.26
6,042.37
6,286.93
5,500.09
5,570.51
5,631.98
5,648.06
Earnings per share (EPS)
34.43
-8.76
-15.25
-0.24
-7.16
-0.74
-11.36
Diluted Earnings per share
34.43
-8.76
-15.25
-0.24
-7.16
-0.74
-11.36
Operating Profit Margin (Excl OI)
49.64%
-19.94%
-49.65%
9.64%
-25.22%
13.25%
-26.06%
Gross Profit Margin
59.6%
-1.86%
-35.27%
15.23%
-1.23%
17.47%
-20.09%
PAT Margin
50.46%
-27.64%
-61.26%
-0.54%
-21.02%
-1.67%
-32.23%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Dec 2025 is 126.11% vs 81.93% in Dec 2024
Consolidate Net Profit
YoY Growth in quarter ended Dec 2025 is 642.94% vs 24.71% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Dec 2025 is 1,579.17% vs 62.80% in Dec 2024
Interest
YoY Growth in quarter ended Dec 2025 is 4.29% vs 566.67% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Dec 2025 has improved from Dec 2024
Compare Quarterly Results Of RaQualia Pharma, Inc. With
Figures in Million
Consolidate Quarterly Results
Change(JPY)
Change(%)
Net Sales
1,668.93
0.00
1,668.93
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,668.93
0.00
1,668.93
Raw Material Cost
242.54
0.00
242.54
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
14.63
0.00
14.63
Selling and Distribution Expenses
234.93
77.49
157.44
203.17%
Other Expenses
34.84
16.24
18.60
114.53%
Total Expenditure (Excl Depreciation)
840.47
239.88
600.59
250.37%
Operating Profit (PBDIT) excl Other Income
828.47
-239.88
1,068.35
445.37%
Other Income
55.30
19.95
35.35
177.19%
Operating Profit (PBDIT)
1,013.83
-219.93
1,233.76
560.98%
Interest
14.63
0.00
14.63
Exceptional Items
-4.52
0.00
-4.52
Gross Profit (PBDT)
1,426.39
0.00
1,426.39
Depreciation
130.06
0.00
130.06
Profit Before Tax
864.61
-219.93
1,084.54
493.13%
Tax
22.51
0.31
22.20
7,161.29%
Provisions and contingencies
0
0
0.00
Profit After Tax
842.10
-220.24
1,062.34
482.36%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
842.10
-220.24
1,062.34
482.36%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
842.10
-220.24
1,062.34
482.36%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
6,896.26
2,376.65
4,519.61
190.17%
Earnings per share (EPS)
34.43
-11.18
45.61
407.96%
Diluted Earnings per share
34.43
-11.18
45.61
407.96%
Operating Profit Margin (Excl OI)
49.64%
0.00%
0.00
49.64%
Gross Profit Margin
59.60%
0.00%
0.00
59.60%
PAT Margin
50.46%
0.00%
0.00
50.46%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 166.89 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is 115.31% vs 35.84% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 126.11% vs 81.93% in Dec 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 84.21 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is 493.14% vs 38.71% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 642.94% vs 24.71% in Dec 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 95.85 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is 2,944.21% vs 79.44% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 1,579.17% vs 62.80% in Dec 2024
Quarterly - Interest
Interest 1.46 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is -3.95% vs -6.17% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 4.29% vs 566.67% in Dec 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 49.64%
in Dec 2025Figures in %
QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025
YoY Growth in quarter ended Dec 2025 has improved from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
